EP0382355A3 - Pullulan und/oder Dextran enthaltende bakterienwachstumsfördernde Substanz - Google Patents
Pullulan und/oder Dextran enthaltende bakterienwachstumsfördernde Substanz Download PDFInfo
- Publication number
- EP0382355A3 EP0382355A3 EP19900300548 EP90300548A EP0382355A3 EP 0382355 A3 EP0382355 A3 EP 0382355A3 EP 19900300548 EP19900300548 EP 19900300548 EP 90300548 A EP90300548 A EP 90300548A EP 0382355 A3 EP0382355 A3 EP 0382355A3
- Authority
- EP
- European Patent Office
- Prior art keywords
- dextran
- pullulan
- promoting agent
- growth promoting
- bacteria containing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229920002307 Dextran Polymers 0.000 title abstract 3
- 229920001218 Pullulan Polymers 0.000 title abstract 3
- 239000004373 Pullulan Substances 0.000 title abstract 3
- 235000019423 pullulan Nutrition 0.000 title abstract 3
- 241000894006 Bacteria Species 0.000 title abstract 2
- 239000003795 chemical substances by application Substances 0.000 title 1
- 230000001737 promoting effect Effects 0.000 title 1
- 241001465754 Metazoa Species 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- FVVCFHXLWDDRHG-UPLOTWCNSA-N (2s,3r,4s,5r,6r)-2-[(2r,3s,4r,5r,6r)-6-[(2s,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)[C@@H](CO)O1 FVVCFHXLWDDRHG-UPLOTWCNSA-N 0.000 abstract 1
- 206010020575 Hyperammonaemia Diseases 0.000 abstract 1
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 abstract 1
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 abstract 1
- 230000003796 beauty Effects 0.000 abstract 1
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 235000013305 food Nutrition 0.000 abstract 1
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 abstract 1
- 229940107187 fructooligosaccharide Drugs 0.000 abstract 1
- 235000021255 galacto-oligosaccharides Nutrition 0.000 abstract 1
- 150000003271 galactooligosaccharides Chemical class 0.000 abstract 1
- 235000013402 health food Nutrition 0.000 abstract 1
- 208000007386 hepatic encephalopathy Diseases 0.000 abstract 1
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 abstract 1
- JCQLYHFGKNRPGE-FCVZTGTOSA-N lactulose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 JCQLYHFGKNRPGE-FCVZTGTOSA-N 0.000 abstract 1
- 229960000511 lactulose Drugs 0.000 abstract 1
- PFCRQPBOOFTZGQ-UHFFFAOYSA-N lactulose keto form Natural products OCC(=O)C(O)C(C(O)CO)OC1OC(CO)C(O)C(O)C1O PFCRQPBOOFTZGQ-UHFFFAOYSA-N 0.000 abstract 1
- 229920001542 oligosaccharide Polymers 0.000 abstract 1
- 150000002482 oligosaccharides Chemical class 0.000 abstract 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/163—Sugars; Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Polymers & Plastics (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Animal Husbandry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- General Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Fodder In General (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2866189 | 1989-02-09 | ||
JP28661/89 | 1989-02-09 | ||
JP1322564A JP2779963B2 (ja) | 1989-02-09 | 1989-12-14 | ビフィズス菌増殖促進剤 |
JP322564/89 | 1989-12-14 |
Publications (3)
Publication Number | Publication Date |
---|---|
EP0382355A2 EP0382355A2 (de) | 1990-08-16 |
EP0382355A3 true EP0382355A3 (de) | 1991-11-13 |
EP0382355B1 EP0382355B1 (de) | 1997-08-20 |
Family
ID=26366798
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP90300548A Expired - Lifetime EP0382355B1 (de) | 1989-02-09 | 1990-01-18 | Bakteriumwachstumsfördernde Substanz enthaltend Pullulan mit oder ohne Dextran |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0382355B1 (de) |
JP (1) | JP2779963B2 (de) |
CA (1) | CA2007270A1 (de) |
DE (1) | DE69031285T2 (de) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3232488B2 (ja) * | 1992-08-20 | 2001-11-26 | 株式会社林原生物化学研究所 | プルラン高含有物とその製造方法並びに用途 |
US20020012985A1 (en) * | 1997-08-21 | 2002-01-31 | Minoru Takebe | Growth promoting material for useful microorganisms and process for producing the same |
CA2330390C (en) * | 1998-04-30 | 2005-11-08 | Morinaga Milk Industry Co., Ltd. | Sugar coated tablets |
DE19836339B4 (de) | 1998-08-11 | 2011-12-22 | N.V. Nutricia | Kohlenhydratmischung |
JP2000169376A (ja) | 1998-12-10 | 2000-06-20 | Suntory Ltd | 高アンモニア血症治療剤 |
ATE270822T1 (de) | 1999-05-20 | 2004-07-15 | Nestle Sa | Verfahren zur erhöhung der propionateproduktion im gastrointestinaltrakt |
JP2001064181A (ja) * | 1999-08-27 | 2001-03-13 | Otsuka Pharmaceut Co Ltd | 免疫賦活組成物 |
US6916796B2 (en) | 2002-06-12 | 2005-07-12 | Abbott Laboratories | Use of pullulan as a slowly digested carbohydrate |
WO2004009800A1 (ja) | 2002-07-22 | 2004-01-29 | Meito Sangyo Co., Ltd | ラクトバシラス・カゼイ 亜種 カゼイ増殖促進用組成物 |
FR2844453B1 (fr) | 2002-09-13 | 2006-05-19 | Agronomique Inst Nat Rech | Utilisation de pre-biotiques pour la prevention de l'installation du diabete de type ii |
WO2004067037A1 (ja) * | 2003-01-30 | 2004-08-12 | Ajinomoto Co., Inc. | 経口腸内環境調整剤および経口正常腸内細菌叢育成キット |
US8685943B2 (en) | 2003-03-12 | 2014-04-01 | Hill's Pet Nutrition, Inc. | Methods for reducing diarrhea in a companion animal |
US20060210606A1 (en) * | 2003-03-26 | 2006-09-21 | Yasumi Yugari | Food for improving clinical conditions capable of lowering the concentration of low-molecular weight nitrogen-containing compounds in blood |
EP1597978A1 (de) | 2004-05-17 | 2005-11-23 | Nutricia N.V. | Synergie von GOS und polyfruktose |
US8252769B2 (en) | 2004-06-22 | 2012-08-28 | N. V. Nutricia | Intestinal barrier integrity |
WO2007011222A2 (en) * | 2005-07-15 | 2007-01-25 | Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno | Cholesterol-lowering food additive |
WO2007095977A1 (en) * | 2005-10-14 | 2007-08-30 | Unilever N.V. | Food product and process for preparing it |
FR2897069B1 (fr) | 2006-02-08 | 2012-06-08 | Centre Nat Rech Scient | Construction de nouveaux variants de l'enzyme dextrane-saccharase dsr-s par ingienerie moleculaire. |
US20120107291A1 (en) * | 2009-06-19 | 2012-05-03 | Danisco A/S | Bifidobacteria for treating diabetes and related conditions |
EP2608678A1 (de) | 2010-08-25 | 2013-07-03 | Tate & Lyle Ingredients Americas LLC | Synbiotisches produkt |
JP5860480B2 (ja) | 2011-01-11 | 2016-02-16 | キャプシュゲル・ベルジウム・エヌ・ヴィ | プルランを含む新しい硬カプセル |
GB201312713D0 (en) | 2013-03-22 | 2013-08-28 | Weaver Connie M | Uses of soluble corn fibre for increasing colonic bacteria populations and increasing mineral absorption |
CN110678170A (zh) | 2017-04-14 | 2020-01-10 | 比利时胶囊公司 | 普鲁兰多糖胶囊 |
CA3059529A1 (en) | 2017-04-14 | 2018-10-18 | Capsugel Belgium Nv | Process for making pullulan |
CN108056226A (zh) * | 2018-01-06 | 2018-05-22 | 吉林大学 | 一种具有调节宠物肠胃功能的添加剂及其制备方法和应用 |
CN108432703A (zh) * | 2018-04-21 | 2018-08-24 | 杭州金知科技有限公司 | 一种鸡养殖方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0153013A2 (de) * | 1984-02-01 | 1985-08-28 | FISONS plc | Orales Dextran enthaltende Zusammensetzungen |
WO1988000830A1 (en) * | 1986-08-02 | 1988-02-11 | Fisons Plc | Use of certain polysaccharides for the treatment of hepatic or renal failure |
EP0363481A1 (de) * | 1987-04-25 | 1990-04-18 | Terumo Kabushiki Kaisha | Nährmittel zur aktivierung der eingeweide |
-
1989
- 1989-12-14 JP JP1322564A patent/JP2779963B2/ja not_active Expired - Fee Related
-
1990
- 1990-01-05 CA CA002007270A patent/CA2007270A1/en not_active Abandoned
- 1990-01-18 DE DE69031285T patent/DE69031285T2/de not_active Expired - Fee Related
- 1990-01-18 EP EP90300548A patent/EP0382355B1/de not_active Expired - Lifetime
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0153013A2 (de) * | 1984-02-01 | 1985-08-28 | FISONS plc | Orales Dextran enthaltende Zusammensetzungen |
WO1988000830A1 (en) * | 1986-08-02 | 1988-02-11 | Fisons Plc | Use of certain polysaccharides for the treatment of hepatic or renal failure |
EP0363481A1 (de) * | 1987-04-25 | 1990-04-18 | Terumo Kabushiki Kaisha | Nährmittel zur aktivierung der eingeweide |
Non-Patent Citations (2)
Title |
---|
CHEM. PHARM. BULL., vol. 26, no. 1, 1978, pages 3306-3311; K. YAZAWA et al.: "Oligosaccharides and polysaccharides specifically utilizable by bifidobacteria" * |
INFECT. IMMUN., vol. 42, no. 2, 1983, pages 716-720, American Society for Microbiology; A.G. KASTER et al.: "Extracellular dextranase activity produced by human oral strains of the genus Bifidobacterium" * |
Also Published As
Publication number | Publication date |
---|---|
DE69031285T2 (de) | 1998-02-12 |
JP2779963B2 (ja) | 1998-07-23 |
EP0382355B1 (de) | 1997-08-20 |
DE69031285D1 (de) | 1997-09-25 |
EP0382355A2 (de) | 1990-08-16 |
CA2007270A1 (en) | 1990-08-09 |
JPH02289520A (ja) | 1990-11-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0382355A3 (de) | Pullulan und/oder Dextran enthaltende bakterienwachstumsfördernde Substanz | |
HU9200249D0 (en) | Veterinary product with delayed active agent activity | |
CA2131168A1 (en) | Decontaminating blood components | |
SE9401406D0 (sv) | Pharmaceutical products for curing tumourous diseases and process for preparing same | |
CA2206490A1 (en) | Processed fish flesh, fish flesh material used the same and method of preparing processed fish flesh | |
FR2541897B1 (fr) | Procede de preparation d'extraits de poissons, mollusques et crustaces utilisables en tant que medicaments, notamment dans le traitement des ulceres, du diabete et des lipemies | |
CA2335308A1 (en) | Protease containing hairball remedy and use thereof | |
NZ504405A (en) | Method for killing bacteria or fungi comprising contacting them mammalian haemoglobin proteins and fragments thereof | |
DE3784628D1 (de) | Dermale behandlung von wurmerkrankungen der katze mit praziquantel. | |
BR0213121A (pt) | modelo in vitro para atividade priocidal | |
BR0210522A (pt) | Processo para tratamento de carcaça de animal | |
KR900012546A (ko) | 꿀벌의 장내 유용균을 혼합한 양봉사료 및 그 사용방법 | |
DE3464362D1 (en) | Microbicidal benzamidine derivatives, their preparation and their use in pharmaceutical compositions as disinfection or preservation agents | |
IE45136L (en) | Rearing of animals | |
KR940000121A (ko) | 자연암토 종이를 혼합한 세라믹 피부미용팩 | |
Szazados | Incidence of bovine salmonellosis and its meat inspectional importance. | |
IL110888A0 (en) | Pharmaceutical compositions for the treatment of liver diseases comprising a benzothiazepine derivative | |
Kinzel | Breaking the Salmonella/chicken connection | |
EP0923369B8 (de) | 1-0-alkylglycerole zum pharmazeutischen oder tierärztlichen gebrauch zur konservierung und/oder verbesserung des samens | |
RU96102950A (ru) | Средство для лечения кожных заболеваний "карталин" | |
曹维霁 et al. | ISOLATION OF TOXOPLASMA GONDII FROM CATS AND GUINEA PIGS IN BEIJING AREA | |
Lupo et al. | A case report of Balantidium coli infection. | |
Schulz et al. | Higher effectiveness of mastitis treatment. | |
IT1282410B1 (it) | Composizione per uso topico ad azione anticellulitica | |
AU2500788A (en) | Veterinary treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): DE FR GB IT SE |
|
RTI1 | Title (correction) | ||
PUAL | Search report despatched |
Free format text: ORIGINAL CODE: 0009013 |
|
AK | Designated contracting states |
Kind code of ref document: A3 Designated state(s): DE FR GB IT SE |
|
17P | Request for examination filed |
Effective date: 19920508 |
|
17Q | First examination report despatched |
Effective date: 19940407 |
|
GRAG | Despatch of communication of intention to grant |
Free format text: ORIGINAL CODE: EPIDOS AGRA |
|
GRAH | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOS IGRA |
|
GRAH | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOS IGRA |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): DE FR GB IT SE |
|
REF | Corresponds to: |
Ref document number: 69031285 Country of ref document: DE Date of ref document: 19970925 |
|
ET | Fr: translation filed | ||
ITF | It: translation for a ep patent filed | ||
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: SE Payment date: 19971211 Year of fee payment: 9 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed | ||
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 19981030 Year of fee payment: 10 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 19990114 Year of fee payment: 10 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 19990119 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 19990225 Year of fee payment: 10 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20000118 |
|
GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20000118 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20000929 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20001101 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: ST |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES;WARNING: LAPSES OF ITALIAN PATENTS WITH EFFECTIVE DATE BEFORE 2007 MAY HAVE OCCURRED AT ANY TIME BEFORE 2007. THE CORRECT EFFECTIVE DATE MAY BE DIFFERENT FROM THE ONE RECORDED. Effective date: 20050118 |